These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 29359980)
1. Genome-wide sequencing and quantification of circulating microRNAs for dogs with congestive heart failure secondary to myxomatous mitral valve degeneration. Jung S; Bohan A Am J Vet Res; 2018 Feb; 79(2):163-169. PubMed ID: 29359980 [TBL] [Abstract][Full Text] [Related]
2. Expression Profiling of Circulating MicroRNAs in Canine Myxomatous Mitral Valve Disease. Li Q; Freeman LM; Rush JE; Laflamme DP Int J Mol Sci; 2015 Jun; 16(6):14098-108. PubMed ID: 26101868 [TBL] [Abstract][Full Text] [Related]
3. Increased NT-proANP predicts risk of congestive heart failure in Cavalier King Charles spaniels with mitral regurgitation caused by myxomatous valve disease. Eriksson AS; Häggström J; Pedersen HD; Hansson K; Järvinen AK; Haukka J; Kvart C J Vet Cardiol; 2014 Sep; 16(3):141-54. PubMed ID: 25130405 [TBL] [Abstract][Full Text] [Related]
4. Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model. Yang VK; Loughran KA; Meola DM; Juhr CM; Thane KE; Davis AM; Hoffman AM J Extracell Vesicles; 2017; 6(1):1350088. PubMed ID: 28804599 [TBL] [Abstract][Full Text] [Related]
5. Plasma and serum serotonin concentrations and surface-bound platelet serotonin expression in Cavalier King Charles Spaniels with myxomatous mitral valve disease. Cremer SE; Kristensen AT; Reimann MJ; Eriksen NB; Petersen SF; Marschner CB; Tarnow I; Oyama MA; Olsen LH Am J Vet Res; 2015 Jun; 76(6):520-31. PubMed ID: 26000599 [TBL] [Abstract][Full Text] [Related]
6. Atrial Fibrillation as a Prognostic Indicator in Medium to Large-Sized Dogs with Myxomatous Mitral Valvular Degeneration and Congestive Heart Failure. Jung SW; Sun W; Griffiths LG; Kittleson MD J Vet Intern Med; 2016; 30(1):51-7. PubMed ID: 26681398 [TBL] [Abstract][Full Text] [Related]
7. Increased serum C-reactive protein concentrations in dogs with congestive heart failure due to myxomatous mitral valve disease. Reimann MJ; Ljungvall I; Hillström A; Møller JE; Hagman R; Falk T; Höglund K; Häggström J; Olsen LH Vet J; 2016 Mar; 209():113-8. PubMed ID: 26831162 [TBL] [Abstract][Full Text] [Related]
8. Echocardiographic parameters for the assessment of congestive heart failure in dogs with myxomatous mitral valve disease and moderate to severe mitral regurgitation. Morgan KRS; Monteith G; Raheb S; Colpitts M; Fonfara S Vet J; 2020 Sep; 263():105518. PubMed ID: 32928487 [TBL] [Abstract][Full Text] [Related]
9. Cardiac troponin-I concentration, myocardial arteriosclerosis, and fibrosis in dogs with congestive heart failure because of myxomatous mitral valve disease. Falk T; Ljungvall I; Zois NE; Höglund K; Olsen LH; Pedersen HD; Häggström J J Vet Intern Med; 2013; 27(3):500-6. PubMed ID: 23551840 [TBL] [Abstract][Full Text] [Related]
11. Markers of Oxidative Stress in Dogs with Myxomatous Mitral Valve Disease are Influenced by Sex, Neuter Status, and Serum Cholesterol Concentration. Reimann MJ; Häggström J; Møller JE; Lykkesfeldt J; Falk T; Olsen LH J Vet Intern Med; 2017 Mar; 31(2):295-302. PubMed ID: 28132441 [TBL] [Abstract][Full Text] [Related]
12. Effect of pimobendan on the incidence of arrhythmias in small breed dogs with myxomatous mitral valve degeneration. Lake-Bakaar GA; Singh MK; Kass PH; Griffiths LG J Vet Cardiol; 2015 Jun; 17(2):120-8. PubMed ID: 26007710 [TBL] [Abstract][Full Text] [Related]
13. Expression Profile of Circulating MicroRNAs in Dogs With Cardiac Hypertrophy: A Pilot Study. Ro WB; Kang MH; Song DW; Lee SH; Park HM Front Vet Sci; 2021; 8():652224. PubMed ID: 33898546 [TBL] [Abstract][Full Text] [Related]
14. Serum Concentrations of Leptin and Adiponectin in Dogs with Myxomatous Mitral Valve Disease. Kim HS; Kang JH; Jeung EB; Yang MP J Vet Intern Med; 2016 Sep; 30(5):1589-1600. PubMed ID: 27573621 [TBL] [Abstract][Full Text] [Related]
15. Plasma and platelet serotonin concentrations in healthy dogs and dogs with myxomatous mitral valve disease. Mangklabruks T; Surachetpong SD J Vet Cardiol; 2014 Sep; 16(3):155-62. PubMed ID: 25127665 [TBL] [Abstract][Full Text] [Related]
16. Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity. Valente C; Guglielmini C; Domenech O; Contiero B; Zini E; Poser H PLoS One; 2020; 15(9):e0238440. PubMed ID: 32870923 [TBL] [Abstract][Full Text] [Related]
17. Partial external mitral annuloplasty in dogs with myxomatous mitral valve degeneration and congestive heart failure: outcome in 9 cases. de Andrade JN; Christopher Orton E; Boon J; Nishimori CT; Olivaes C; Camacho AA J Vet Cardiol; 2011 Sep; 13(3):197-201. PubMed ID: 21824833 [TBL] [Abstract][Full Text] [Related]
18. Mitral valve transcriptome analysis in thirty-four age-matched Cavalier King Charles Spaniels with or without congestive heart failure caused by myxomatous mitral valve disease. Reimann MJ; Cremer S; Christiansen L; Ibragimov E; Gao F; Cirera S; Fredholm M; Olsen LH; Karlskov-Mortensen P Mamm Genome; 2024 Mar; 35(1):77-89. PubMed ID: 37938355 [TBL] [Abstract][Full Text] [Related]
19. Tissue Doppler and strain imaging in dogs with myxomatous mitral valve disease in different stages of congestive heart failure. Tidholm A; Ljungvall I; Höglund K; Westling AB; Häggström J J Vet Intern Med; 2009; 23(6):1197-207. PubMed ID: 19909428 [TBL] [Abstract][Full Text] [Related]
20. Neutrophil-to-lymphocyte ratio is increased in dogs with acute congestive heart failure secondary to myxomatous mitral valve disease compared to both dogs with heart murmurs and healthy controls. DeProspero DJ; Hess RS; Silverstein DC J Am Vet Med Assoc; 2023 Nov; 261(11):1-8. PubMed ID: 37406992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]